-
公开(公告)号：EP2680830A2
公开(公告)日：2014-01-08
申请号：EP12751765.4
申请日：2012-02-28
CPC分类号： A61K31/14 , A61K9/10 , A61K9/16 , A61K31/15 , A61K31/20 , A61K31/23 , A61K31/685 , A61K2300/00
摘要： Urinary incontinence is treated by administration of pharmaceutical compositions containing at least one nitrone spin trap such as α-phenyl t-butyl nitrone (PBN) and derivatives thereof. Preferred compositions and methods of treatment further comprise at least one adjunctive ingredient including fatty acid esters of ascorbic acid such as ascorbyl palmitate and ascorbyl stearate, and polyenylphosphatidylcholine.
-
公开(公告)号：EP2519246A1
公开(公告)日：2012-11-07
申请号：EP10779178.2
申请日：2010-11-09
CPC分类号： A61K38/063
摘要： Topical compositions to treat inflammatory skin conditions such as psoriasis comprise an effective amount of S-acyl glutathione derivative and a carrier. Methods for treating inflammatory skin conditions such as psoriasis comprise applying a composition containing S-acyl glutathione derivative in a dermatologically acceptable carrier to skin tissue. The acyl group is a saturated or unsaturated aliphatic C1
2 -C
24 group, preferably an unsaturated C
16 - C
24 group, most preferably an unsaturated C
18 group. In particularly preferred embodiments, the acyl group is a linoleoyl group.摘要翻译： 治疗炎症性皮肤病如牛皮癣的局部组合物包含有效量的S-酰基谷胱甘肽衍生物和载体。 治疗炎性皮肤病如银屑病的方法包括将含有S-酰基谷胱甘肽衍生物的组合物在皮肤病学可接受的载体中施用于皮肤组织。 酰基是饱和或不饱和脂族C12-C24基团，优选不饱和C16-C24基团，最优选不饱和C18基团。 在特别优选的实施方案中，酰基是亚油酰基。
-
公开(公告)号：EP2658534B1
公开(公告)日：2018-01-31
申请号：EP11813932.8
申请日：2011-12-30
摘要： Psoriasis is treated by application of a composition containing a nitrone spin trap such as α-phenyl t-butyl nitrone (PBN) and derivatives thereof. Preferred compositions and method of treatments further comprise at least one adjunctive ingredient including fatty acid esters of ascorbic acid such as ascorbyl palmitate and ascorbyl stearate, and polyenylphosphatidylcholine.
-
公开(公告)号：EP1735583A2
公开(公告)日：2006-12-27
申请号：EP05795176.6
申请日：2005-03-31
IPC分类号： F42B12/42
摘要： A countermeasure device (10) for negating a guidance seeking system is provided. The countermeasure device (10) includes a membrane (12) defining an internal chamber (14), a gas disposed in the chamber (14), and an illuminating device (30). The illuminating device (30) includes a light source (32) producing energy sufficient to provide a decoy signature detectable by the guidance seeking system and a power supply (34) coupled to the light source (32). In one embodiment the light source (32) is a light emitting diode. In another embodiment, the light source (32) is a laser diode.
-
5.发明公开TOPICAL NITRONE SPIN TRAP COMPOSITIONS FOR PSORIASIS 有权TOPISCHE NITRONEN-SPIN-TRAPPING-ZUSAMMENSETZUNGENFÜRPSORIASIS
公开(公告)号：EP2658534A1
公开(公告)日：2013-11-06
申请号：EP11813932.8
申请日：2011-12-30
摘要： Psoriasis is treated by application of a composition containing a nitrone spin trap such as α-phenyl t-butyl nitrone (PBN) and derivatives thereof. Preferred compositions and method of treatments further comprise at least one adjunctive ingredient including fatty acid esters of ascorbic acid such as ascorbyl palmitate and ascorbyl stearate, and polyenylphosphatidylcholine.
摘要翻译： 通过施用含有硝基自旋捕获剂如α-苯基叔丁基硝酮（PBN）及其衍生物的组合物来治疗牛皮癣。 优选的组合物和处理方法还包括至少一种辅助成分，包括抗坏血酸的脂肪酸酯如棕榈酸抗坏血酸酯和抗坏血酸硬脂酸酯，以及聚烯基磷脂酰胆碱。
-
6.发明公开Topical Anesthetic Uses of Szeto-Schiller Peptides 审中-公开TopischeanästhetischeVerwendungen von Szeto-Schiller-Peptiden
公开(公告)号：EP2436390A1
公开(公告)日：2012-04-04
申请号：EP11183581.5
申请日：2011-09-30
IPC分类号： A61K38/07 , A61K38/08 , A61K38/10 , A61K31/137 , A61K45/06 , A61K47/18 , A61K47/24 , A61K9/00 , A61P23/02
CPC分类号： A61K38/07 , A61K9/0014 , A61K31/137 , A61K38/08 , A61K38/10 , A61K45/06 , A61K2300/00
摘要： Topical anesthetic compositions include Szeto-Schiller peptides and a dermatologically acceptable carrier, and optionally a vasoconstrictor and tyrosine. A method of providing local analgesia to the skin involves applying to skin the topical anesthetic compositions.
摘要翻译： 局部麻醉剂组合物包括Szeto-Schiller肽和皮肤病学可接受的载体，以及任选的血管收缩剂和酪氨酸。 向皮肤提供局部止痛的方法涉及将外用麻醉剂组合物施用于皮肤。
-
公开(公告)号：EP1401418A2
公开(公告)日：2004-03-31
申请号：EP02739748.8
申请日：2002-06-06
IPC分类号： A61K31/13 , A61K31/195 , A61K31/385
CPC分类号： A61Q19/00 , A61K8/0208 , A61K8/38 , A61K8/41 , A61K8/44 , A61K8/4986 , A61K31/13 , A61K31/131 , A61K31/133 , A61K31/195 , A61K31/385 , A61K45/06 , A61K2800/75 , A61K2800/83 , A61Q5/02 , A61Q17/00 , A61K2300/00
摘要： Skin, hair and nails are treated by topical application of compositions containing an alkanolamine such as dimethylaminoethanol to increase smoothness and surface uniformity. Application to the skin visibly decreases pore size, treats or prevents acne, diminishes or prevents cutaneous scar tissue, and/or provides a pretreatment prior to applying electrical pulses sufficient to contract subcutaneous muscles underlying the skin. Application to the hair, fingernails or toenails increases elasticity, enhances shine, and provides emolliency to keratin. Alkanolamine compositions contain at least one other adjunct ingredient such as tyrosine, lipoic acid, an α-hydroxy acid, or a fatty acid ester of ascorbic acid in most embodiments.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.012 秒)
